Cannabis consumption and psychosis or schizophrenia development

  title={Cannabis consumption and psychosis or schizophrenia development},
  author={Mar{\'i}a Bettina Ortiz-Medina and Marta Perea and Julio Torales and Antonio Ventriglio and Giovanna Vitrani and Lourdes Aguilar and Carlos Roncero},
  journal={International Journal of Social Psychiatry},
  pages={690 - 704}
Objective: Cannabis consumption produces psychopathology, in some cases psychotic episodes, which are of our interest in this work. However, the relationship between cannabis use and psychosis has not been fully elucidated. The objectives of this work are to (1) review the current state of knowledge on the association of cannabis use with the risk of the development of psychosis or psychotic symptoms in people without schizophrenia and (2) assess the consistency of the hypothesis that cannabis… 

Figures and Tables from this paper

Cannabis and Psychosis: A Review of the Risk Factors Involved
A significant inverse relationship exists between cannabidiol (CBD) and psychosis: cannabodiol is associated with less psychotic symptoms and manifests antipsychotic properties.
Cannabis use in individuals at clinical high-risk for psychosis: a comprehensive review
Cannabis use has not been thoroughly researched regarding frequency and dose of use, and how other factors, such as symptoms, are associated with cannabis in CHR individuals.
Duration of Untreated Disorder and Cannabis Use: An Observational Study on a Cohort of Young Italian Patients Experiencing Psychotic Experiences and Dissociative Symptoms
A longer DUP was associated with worse symptoms and cannabis use did not seem to affect the DUP, but both were related with more dissociative symptoms at onset and over time.
Cannabis and schizophrenia: characterisation of a risk factor in a sample of Moroccan patients hospitalised for psychosis
It is suggested that there is a causal relationship between cannabis use and/or dependence (problematic use) and the onset and/ or worsening of schizophrenic disorder.
Schizophrenia and substance use disorder: a retrospective study of a dual diagnosis patients cohort
It is verified that the consumption of psychoactive substances is associated with the early age at the first hospitalization, whit the reduced compliance to treatment and the increased number of hospitalizations.
The why behind the high: determinants of neurocognition during acute cannabis exposure.
There is evidence that the neurocognitive response to acute cannabis exposure is driven by changes in the activity of the mesocorticolimbic and salience networks, which varies with product formulations and frequency of use and can differ between recreational and therapeutic use.
Primary Psychosis: Risk and Protective Factors and Early Detection of the Onset
According to this evidence, the study of the determinants of primary psychosis has a pivotal role in designing and promoting preventive policies aimed at reducing the burden of disability and suffering of the disorder.
Medical Cannabis in Children
The main risks associated with use of Δ9-tetrahydrocannabinol (THC) and CBD in the pediatric population are described, as well as the debate regarding the use of whole-plant extract to retain a possible “entourage effect” as opposed to pure cannabinoids that are more standardized and reproducible.
Cannabis Use Induces Distinctive Proteomic Alterations in Olfactory Neuroepithelial Cells of Schizophrenia Patients
Findings indicate that RNA-related proteins might be relevant to understand the influence of cannabis use on schizophrenia (SCZ), and are correlated with cognitive performance and clinical scores.
Cannabinoids and psychosis: current challenges of mechanistic toxicology


Cannabis use and the risk of later schizophrenia: a review.
Antecedent cannabis use appears to act as a risk factor in the onset of schizophrenia, especially in vulnerable people, but also in people without prior history.
Cannabis use and psychotic disorders: an update.
This paper evaluates three hypotheses about the relationship between cannabis use and psychosis in the light of recent evidence from prospective epidemiological studies, finding reasonable evidence for the third hypothesis that cannabis use exacerbates psychosis.
Cannabis Use and Psychosis: A Review of Clinical and Epidemiological Evidence ∗
It is still unclear whether this means that cannabis use precipitates schizophrenia, whether cannabis use is a form of ‘self-medication’, or whether the association is due to the use of other drugs, such as amphetamines, which heavy cannabis users are more likely to use.
Cannabis use and risk of psychosis: an etiological link?*
A dose-response relationship was found between cannabis exposure and risk of psychosis, and this association was independent from potential confounding factors such as exposure to other drugs and pre-existence of psychotic symptoms.
Cannabis and psychosis
The evidence suggests that common factors do not explain the comorbidity between cannabis use and psychosis, and it is unlikely that cannabis use causes psychosis among persons who would otherwise not have developed the disorder.
Causal association between cannabis and psychosis: examination of the evidence
Cases of psychotic disorder could be prevented by discouraging cannabis use among vulnerable youths and research is needed to understand the mechanisms by which cannabis causes psychosis.
[A review about cannabis use like as risk factor of schizophrenia].
It is considered that the use of cannabis is clearly associated with the inducement of psychotic symptoms and is, possibly, a risk factor of schizophrenia in people with a genetic or psychosocial vulnerability, preventive methods being necessary in high-risk groups.
Cannabis and psychosis/schizophrenia: human studies
Converting lines of evidence suggest that cannabinoids can produce a full range of transient schizophrenia-like positive, negative, and cognitive symptoms in some healthy individuals, and novel hypotheses including the role of cannabinoids on neurodevelopmental processes relevant to psychotic disorders are being studied.
Cannabis and Psychosis: What is the Link?
Although there is evidence that cannabis use increases the risk of developing psychotic symptoms, the causal nature of this association remains unclear, and this conclusion should be mitigated by uncertainty arising from cannabis use assessment, psychosis measurement, reverse causality and control of residual confounding.
Is Cannabis Use a Contributory Cause of Psychosis?
  • L. Degenhardt, W. Hall
  • Psychology, Medicine
    Canadian journal of psychiatry. Revue canadienne de psychiatrie
  • 2006
It is most plausible that cannabis use precipitates schizophrenia in individuals who are vulnerable because of a personal or family history of schizophrenia.